The following is from The Vaccine Reaction. On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and Sanofi’s new nirsevimab (Beyfortus) monoclonal antibody drug believed to […]
12 infant deaths reported in clinical trials for FDA-endorsed RSV drug Read More »
Most voters suspect U.S. officials covered up China’s role in the Covid-19 pandemic, and less than half think Dr. Anthony Fauci has told the truth about the research that may have caused the outbreak. That’s according to the latest Rasmussen
(POLL) Voters: Nearly half say Dr. Fauci covered-up truth on Covid-19 Read More »
The following is from Becker’s Hospital Review. U.S. News & World Report released its Best Children’s Hospitals rankings for 2023-24 on June 21, with Cincinnati Children’s Hospital Medical Center earning the top spot for the first time. The rankings reflect measures such
US News’ Rankings: Cincinnati Children’s Medical Center takes top honor for 1st time Read More »
The following is from The Vaccine Reaction. With Rochelle Walensky, MD, MPH set to officially leave her post as director of the U.S. Centers for Disease Control and Prevention (CDC) on June 30, 2023, there has been surprisingly little attention
The following is from The Defender. The latest weight loss craze to hit Hollywood and beyond is semaglutide, more popularly known as Ozempic, the brand name of the drug marketed to improve blood sugar in people with Type 2 diabetes. Semaglutide
The following is from Becker’s Hospital Review. FDA investigators discovered more quality issues at an Intas Pharmaceuticals factory in Ahmedabad, India, which halted some production after a November inspection found a truck full of shredded documents, Bloomberg reported June 15. In May,
Drug shortages for cancer patients could worsen due to quality control issues Read More »
(Originally aired Oct. 23, 2022) How happy do you feel today? It’s more than just a polite social question. How happy or unhappy we are may be one of the most important but least-noticed societal measures. We talk about that
Public Citizen’s Health Research Group wants the FDA to deny speeded up approval of a new gene therapy treatment. The advocacy group states that the treatment, SRP-9001 (Sarepta Therapeutics) for ambulatory Duchenne muscular dystrophy (DMD), intended for children aged four
(READ) Watchdogs want FDA to reject fast-tracking of new gene therapy treatment Read More »
